Samsung Expands Galaxy AI as Consumer Desire for Mobile AI Grows
Major commitment announced during Galaxy AI Forum at Galaxy Unpacked
Samsung has today announced a major commitment to expand Galaxy AI to over 400 million devices globally by the end of 2025. This builds on its 2024 milestone of bringing Galaxy AI to more than 200 million devices, beginning with the Galaxy S24 series.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250711123209/en/
Galaxy AI adoption accelerates, with 70% of Galaxy S25 users engaging AI-powered features like Circle to Search, Photo Assist, and Note Assist
Since launch, Galaxy AI has helped define a new era of mobile AI innovation – transforming what’s possible on smartphones. Today, over 70% of Galaxy S25 users actively engage with a growing suite of AI-powered features developed in collaboration with Samsung and Google.
Among these, Google Gemini has seen the most notable growth, with usage tripling across the latest Galaxy S series. Through close collaboration with Samsung, Gemini is deeply integrated across Galaxy devices – connecting with first-party apps to deliver helpful and personalised responses.
Mindy Brooks, Vice President, Android Consumer Product & Experience, Google, said: "Through close collaboration with Samsung, Gemini works seamlessly across its devices and connects with its first-party apps to provide helpful and personalised responses. For example, Gemini’s live video capabilities have been optimized for the Flip's front screen camera, and Gemini on Galaxy Watch leverages context from your phone."
Consumers Are Turning to Mobile AI for Everyday Tasks
One year on from the inaugural Galaxy AI Forum, Samsung is sharing new insights into how AI is transforming daily life. Research conducted with Symmetry Research reveals growing reliance on mobile AI and evolving expectations for more personalised, proactive features:
- 47% of consumers say their daily routines would be disrupted without AI tools such as personalised notifications, AI-powered search, and voice assistance.
- 45% now use voice commands as often as they type – highlighting a shift in how users interact with their devices.
These trends point to growing demand for multimodal, intelligent, and intuitive AI experiences.
Democratising Mobile AI for All
Samsung’s expansion of Galaxy AI to 400 million devices reflects its commitment to democratising the power and possibilities of mobile AI. Whether through intuitive voice features, on-device privacy, or cross-device intelligence, Samsung is building a future where AI is seamlessly embedded in the smartphone – the device that’s always in your hand.
Jisun Park, Corporate Executive Vice President & Head of Language AI Team, Mobile eXperience Business at Samsung Electronics, concluded: “Some see AI as the start of a ‘post smartphone’ era, but we see it differently. We’re building a future where your devices don’t just respond, they become smarter to anticipate, see, and work quietly in the background to make life feel a little more effortless.”
Learn more about how Samsung and its industry partners are shaping the future of mobile AI here: https://www.samsungmobilepress.com/feature-stories/samsung-continues-to-expand-galaxy-ai-as-consumers-show-increasing-reliance-on-mobile-ai
View source version on businesswire.com: https://www.businesswire.com/news/home/20250711123209/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kihealth Wins Innovation of the Year at ADA 85th Scientific Sessions for Groundbreaking Diabetes Diagnostic14.7.2025 15:04:00 CEST | Press release
Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago. Kihealth’s pioneering liquid-biopsy test, which measures the rate of pancreatic beta‑cell death, earned top honors among five finalists for its potential to revolutionize early diabetes detection. Dubbed the “Super Bowl of diabetes innovation,” this prestigious award has firmly established Kihealth and its products in the spotlight. The honor follows a live pitch to a panel of expert judges and a global audience of clinicians, researchers, and industry leaders. In winning first place, Kihealth stood out for delivering a novel diagnostic that provides patients and clinicians with a critical early window into metabolic health – years before glucose or A1c abnormalities appear prnewswire.com. Key Highlights & Immediate ImpactSurge in physician engagement: Following the win, Kihealth has received new con
CSC Research Finds 40% of Enterprises Could Be at Risk of an Outage Due to SSL Expiration14.7.2025 15:00:00 CEST | Press release
Domain control validation sunsets on July 15, 2025, putting many companies that rely on WHOIS email at risk for service disruption New research fromCSC, an enterprise-class domain security provider and world leader in domain management, SSL management, brand protection, and anti-fraud solutions, indicates that as many as 40% of enterprises are at risk of unexpected service outages caused by out-of-date secure sockets layer (SSL) certificates. This threat stems from the reliance on WHOIS-based email addresses for domain control validation (DCV) that will be officially deprecated on July 15, 2025. CSC analyzed over 100,000 global SSL certificate records and found that many organizations still use WHOIS email as their primary method for domain control validation, despite a 2024 vote by the CA/Browser Forum that mandates the deprecation of WHOIS-based validation due to its associated security vulnerabilities. After July 15, 2025, certificate authorities (CAs) will no longer accept WHOIS em
SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion14.7.2025 15:00:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company’s strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/ Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With over 30 years of clinical experience, he is widely known for his pioneering work in regenerative aesthetics, including the clinical application of fat-derived stem cells, skeletal facial aesthetic surgery, and the integration of artificial intelligence into medical in
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala14.7.2025 14:30:00 CEST | Press release
Investment Will Accelerate PCI’s Leading Position in CDMO, Delivering Life-Changing Therapies to PatientsTransaction Includes Continued Investment from Partners Group PCI Pharma Services (“PCI” or the “Company”), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, today announced that it received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company (“Mubadala”). Partners Group will also continue to support the Company with a minority investment. Financial terms of the private transaction were not disclosed. Headquartered in Philadelphia, Pennsylvania, PCI provides clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products’ speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 450 successful pr
Stone Point Capital Closes Tenth Flagship Fund with $11.5 Billion of Committed Capital14.7.2025 14:30:00 CEST | Press release
Fund Surpassed Hard Cap and Is the Largest Fundraise in the Firm’s History Stone Point Capital LLC, a private equity firm focused on financial services and related industries, today announced the final closing of its tenth private equity fund, Trident X, with $11.5 billion in total commitments. Trident X exceeded its original target and hard cap of $9 billion and is approximately $2.5 billion larger than Trident IX, a $9 billion fund, which closed in 2022. Trident X received strong support from its existing investor base, as well as first-time commitments from a number of leading institutional investors globally. General Partner and affiliated entities contributed approximately $750 million. “We are grateful to our limited partners for their continued trust and support, and we are proud of the enduring strength of our Trident Funds over 30 years and many market cycles,” said Chuck Davis, Chairman and Co-Chief Executive Officer of Stone Point Capital. “With Trident X, we will continue d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom